PPARγ knockdown by engineered transcription factors:: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis

被引:291
作者
Ren, DL
Collingwood, TN
Rebar, EJ
Wolffe, AP
Camp, HS [1 ]
机构
[1] Pfizer Global & Res Dev, Dept Mol Sci & Technol, Ann Arbor, MI 48105 USA
[2] Sangamo BioSci Inc, Richmond, CA 94804 USA
关键词
PPAR gamma 1; PPAR gamma 2; adipogenesis; zinc finger protein;
D O I
10.1101/gad.953802
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To determine functional differences between the two splice variants of PPARgamma (gamma1 and gamma2), we sought to selectively repress gamma2 expression by targeting engineered zinc finger repressor proteins (ZFPs) to the gamma2-specific promoter, P2. In 3T3-L1 cells, expression of ZFP55 resulted in >50% reduction in gamma2 expression but had no effect on gamma1, whereas adipogenesis was similarly reduced by 50%. However, ZFP54 virtually abolished both gamma2 and gamma1 expression, and completely blocked adipogenesis. Overexpression of exogenous gamma2 in the ZFP54-expressing cells completely restored adipogenesis, whereas overexpression of gamma1 had no effect. This finding clearly identifies a unique role for the PPARgamma2 isoform.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 30 条
[1]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[2]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[3]  
Bartsevich VV, 2000, MOL PHARMACOL, V58, P1
[4]   Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations [J].
Beamer, BA ;
Yen, CJ ;
Andersen, BE ;
Muller, D ;
Elahi, D ;
Cheskin, LJ ;
Andres, R ;
Roth, J ;
Shuldiner, AR .
DIABETES, 1998, 47 (11) :1806-1808
[5]   Positive and negative regulation of endogenous genes by designed transcription factors [J].
Beerli, RR ;
Dreier, B ;
Barbas, CF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1495-1500
[6]   PPARγ activators down-regulate the expression of PPARγ in 3T3-L1 adipocytes [J].
Camp, HS ;
Whitton, AL ;
Tafuri, SR .
FEBS LETTERS, 1999, 447 (2-3) :186-190
[7]   A novel potent antagonist of peroxisome proliferator-activated receptor γ blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes [J].
Camp, HS ;
Chaudhry, A ;
Leff, T .
ENDOCRINOLOGY, 2001, 142 (07) :3207-3213
[8]   REGULATED EXPRESSION OF 3 C/EBP ISOFORMS DURING ADIPOSE CONVERSION OF 3T3-L1 CELLS [J].
CAO, ZD ;
UMEK, RM ;
MCKNIGHT, SL .
GENES & DEVELOPMENT, 1991, 5 (09) :1538-1552
[9]   SELECTION OF DNA-BINDING SITES FOR ZINC FINGERS USING RATIONALLY RANDOMIZED DNA REVEALS CODED INTERACTIONS [J].
CHOO, Y ;
KLUG, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11168-11172
[10]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287